Previous Page  3 / 5 Next Page
Information
Show Menu
Previous Page 3 / 5 Next Page
Page Background

allied

academies

Page 23

Notes:

Journal of Diabetology | Volume 3

May 16-17, 2019 | Prague, Czech Republic

Diabetes and Endocrinology

27

th

International Conference on

J Diabetol, Volume 3

Diabetes: Scenario, nutrition and enteral nutritional therapy

Pollyana Araújo Corrêa

Nestle Health Science, Brazil

D

iabetes mellitus (DM) is an important and growing health

problem for all countries, regardless of their degree of

development. In 2015, the International Diabetes Federation

(IDF) estimated that 8.8% (95% confidence interval: 7.2 to

11.4) of the world population aged 20-79 years (415 million

of people) lived with diabetes. If current trends persist, the

number of people with diabetes was projected to exceed 642

million by 2040. The increase in the prevalence of diabetes is

associated with several factors, such as: rapid urbanization,

epidemiological transition, nutritional transition, greater

frequency of sedentary lifestyle, greater frequency

of overweight, growth and population aging, and also

greater individual’s survival with diabetes. The World Health

Organization estimates that high glycemia is the third major

factor in the cause of premature mortality, surpassed only

by increased blood pressure and tobacco use. Nutritional

care in diabetes mellitus (DM) is one of the most challenging

parts of treatment and lifestyle change strategies, as well

as in hospitalized patients in Enteral Nutritional Therapy.

International recommendations on enteral nutritional

therapy (NER) in diabetes were initiated in 1998, when the

ADA and the European Association for the Study of Diabetes

(EASD) developed in Chicago, consensus that has established

proposals for this purpose. The latest consensus published by

the ADA recommends the presence of a registered dietitian

in the hospital team to conduct a realistic plan on nutritional

therapy. A recent study including patients with DM2, admitted

to intensive care units (ICUs), showed that the use of a

specialized formula in glycemic control was correlated with

a reduction in mortality and with better economic results.

Speaker Biography

Pollyana Araújo Corrêa has graduated in nutrition at the age of 22 years

from Universidade Católica de Brasília and she also had a graduation in

Business Management, Comptroller and Corporate Finance from IPOG, BR.

She is a technical advisor of clinical nutrition at Nestlé Health Science in

Brasília, BR, workingwith enteral nutritional therapy in various pathologies.

e:

pollyana.correa@gmail.com